News & Updates

Transdermal Testosterone Gel (Androgel®): A breakthrough in Testosterone Replacement Therapy (TRT)

Key points:

• TRAVERSE trial provides reassurance on testosterone replacement therapy (TRT) safety in hypogonadal men
• TRT shifts views as additional testosterone fails to stimulate prostate tissue growth
• Meta-analysis shows TRT’s positive effects on body composition and cardiovascular health
• Androgel® heralded as a viable treatment of choice for Filipino men with low testosterone
• Collaborative care between urologists and mental health experts encourages improved management of testosterone deficiency

Lebrikizumab improves anxiety, depression symptoms in adolescents with AD

Lebrikizumab improves anxiety and depression symptoms, as shown by PROMIS* scores, in patients with moderate-to-severe atopic dermatitis (AD), according to the ADore trial presented at AAAAI/WAO 2025.

Impulse control tied to ejaculation time in men with PE

Impulse control appears to be associated with ejaculation time in men with premature ejaculation (PE), suggest the results of a cross-sectional observational study.

MVM supplementation may improve mood, lower loneliness in older adults

Twelve weeks of multivitamin-mineral (MVM) supplementation increases friendliness and reduces perceived stress reactivity and emotional loneliness in older adults, a study has shown.

Xanomeline/trospium improves cognition in acute schizophrenia patients with impairment

The use of xanomeline/trospium chloride brings significant cognitive improvements to acute schizophrenia patients with prespecified impairments compared with placebo, a study has shown.

Ondansetron plus SRI eases OCD severity

Treatment with high-dose ondansetron shows no effect on sensory phenomena (SP) in patients with obsessive-compulsive disorder (OCD), according to a study.

Spaced tDCS safe, feasible for major depression

The use of spaced transcranial direct current stimulation (tDCS) significantly reduces symptoms in patients with major depressive disorder (MDD), with no serious adverse events (AEs), reports a study.